Hypovitaminosis D and the endocrine phenotype of COVID-19.

Abstract excerpt

BACKGROUND: Vitamin D and its deficiency have recently been suspected to be involved in increased susceptibility and negative outcomes of COVID-19. This assumption was based on the well known immunomodulatory actions of vitamin D and on the consistent finding of low levels of 25 hydroxyvitamin D (25OHD) in hospitalized patients with COVID-19. Moreover, several studies reported a correlation between 25OHD levels...

Topics

Join the communities discussing this publication.

• COVID-19
• COVID-19 Clinical Research Studies
• Phenotype
• SARS-CoV-2
• Vitamin D
• Vitamin D Deficiency